BP and Kidney Disease Progression in Advanced CKD
Clinical Journal of the American Society of Nephrology · 2025-09 · 20 (9) · 1179-1189
DOI: 10.2215/cjn.0000000760 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Journal of the American Society of Nephrology, online erschienen am 06.06.2025. Verfasst von Cheol Ho Park und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Institute of Kidney Disease Research, Yonsei University College of Medicine, Seoul, Republic of Korea. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Korea Disease Control and Prevention Agency, NCRR NIH HHS, NIDDK NIH HHS.
Abstract (Originalsprache)
Key Points Higher BP was associated with a higher risk of kidney disease progression in patients with CKD G3b–G5. A stronger association observed with time-updated BP emphasizes the importance of consistently maintaining optimal BP over time. Further validation through well-designed clinical trials is warranted to determine optimal BP in patients with CKD.
Background
BP control is important in the management of CKD. However, in patients with advanced CKD, the benefits of BP control in delaying the progression of CKD remain uncertain.
Methods
We analyzed 2939 participants with CKD G3b–G5 (eGFR
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Internal Medicine, Institute of Kidney Disease Research, Yonsei University College of Medicine, Seoul, Republic of Korea.
- Institute for Innovation in Digital Healthcare, Yonsei University, Seoul, Republic of Korea.
- Department of Internal Medicine, National Health Insurance Service Medical Center, Ilsan Hospital, Goyang, Republic of Korea.
- Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea.
- Department of Epidemiology, Tulane University School of Public Health and Tropical Medicine, New Orleans, Louisiana.
- Department of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
ORCID-Profile: Cheol Ho Park, Jung Tak Park, Tae Ik Chang, Tae-Hyun Yoo, Kook-Hwan Oh, Amanda H Anderson, Wei Yang, Mahboob Rahman, Seung Hyeok Han
Förderung
- Korea Disease Control and Prevention Agency
- NCRR NIH HHS
- NIDDK NIH HHS
- NCATS NIH HHS
- NIGMS NIH HHS
- National Institute of Health
- National Institute of Diabetes and Digestive and Kidney Diseases
- National Center for Advancing Translational Sciences
Zitieren
APA
Park, C. H., Kim, H. W., Park, J. T., Chang, T. I., Yoo, T. H., Oh, K. H., Anderson, A. H., Yang, W., Cohen, J. B., Rahman, M., Kang, S. W., Han, S. H., & on the behalf of CRIC Study and KNOW-CKD Investigators (2025). BP and Kidney Disease Progression in Advanced CKD. Clinical Journal of the American Society of Nephrology, 20(9), 1179-1189. https://doi.org/10.2215/cjn.0000000760
Vancouver
Park CH, Kim HW, Park JT, Chang TI, Yoo TH, Oh KH, et al. BP and Kidney Disease Progression in Advanced CKD. Clinical Journal of the American Society of Nephrology. 2025;20(9):1179-1189. doi:10.2215/cjn.0000000760
BibTeX
@article{Park2025,
author = {Park, Cheol Ho and Kim, Hyung Woo and Park, Jung Tak and Chang, Tae Ik and Yoo, Tae-Hyun and Oh, Kook-Hwan and Anderson, Amanda H and Yang, Wei and Cohen, Jordana B and Rahman, Mahboob and Kang, Shin-Wook and Han, Seung Hyeok and on the behalf of CRIC Study and KNOW-CKD Investigators, on the behalf of CRIC Study and KNOW-CKD Investigators},
title = {BP and Kidney Disease Progression in Advanced CKD},
journal = {Clinical Journal of the American Society of Nephrology},
year = {2025},
volume = {20},
number = {9},
pages = {1179--1189},
doi = {10.2215/cjn.0000000760}
}
EUVIMED